The Current Ratio as of September 2024 (TTM) for Bone Biologics Corporation (BBLG) is 11.22

According to Bone Biologics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 11.22. This represents a change of 3.81% compared to the average of 10.81 of the last 4 quarters.

Bone Biologics Corporation (BBLG) Historical Current Ratio (quarterly & annually)

How has BBLG Current Ratio performed in the past?

The mean historical Current Ratio of Bone Biologics Corporation over the last ten years is 7.79. The current 11.22 Current Ratio has changed 14.31% with respect to the historical average. Over the past ten years (40 quarters), BBLG's Current Ratio was at its highest in in the March 2022 quarter at 110.97. The Current Ratio was at its lowest in in the December 2020 quarter at -0.03.

Bone Biologics Corporation (BBLG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bone Biologics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bone Biologics Corporation (BBLG) Average Current Ratio

How has BBLG Current Ratio performed in the past?

The current Current Ratio of Bone Biologics Corporation (BBLG) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Bone Biologics Corporation (BBLG) Current Ratio vs. Peers

How is BBLG’s Current Ratio compared to its peers?

Bone Biologics Corporation’s Current Ratio is greater than Bluejay Diagnostics, Inc. (4.38), greater than Talis Biomedical Corporation (7.76), greater than Nuwellis, Inc. (1.20), greater than Heart Test Laboratories, Inc. (4.49), greater than Tivic Health Systems, Inc. (7.89), greater than Vivos Therapeutics, Inc. (1.18), greater than Rapid Micro Biosystems, Inc. (5.92), greater than INVO Bioscience, Inc. (0.30), greater than Tenon Medical, Inc. (1.20), greater than Motus GI Holdings, Inc. (1.74), greater than NanoVibronix, Inc. (2.11), greater than Sintx Technologies, Inc. (1.94), greater than ReShape Lifesciences Inc. (1.90), greater than Ra Medical Systems, Inc. (2.84),

Build a custom stock screener for Bone Biologics Corporation (BBLG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Biologics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bone Biologics Corporation (BBLG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bone Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.